REBECCA OTTO: Open Payments
NPI 1063271146 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 25 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $327 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $91 |
| Amgen Inc. | 3 | $77 |
| GlaxoSmithKline, LLC. | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Novo Nordisk Inc | 2 | $47 |
| PFIZER INC. | 2 | $38 |
| Medtronic, Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
Products named: TRELEGY ELLIPTA, Kerendia, KRYSTEXXA, BREZTRI, ROTATEQ, Ozempic, OTEZLA, PAXLOVID.
Industry payments across NV — which companies pay providers there.
